Viveve Medical Inc. (VIVE)

6.17
NASDAQ : Health Technology
Prev Close 7.56
Day Low/High 5.73 / 7.44
52 Wk Low/High 6.72 / 371.00
Avg Volume 4.99M
Exchange NASDAQ
Shares Outstanding 46.61M
Market Cap 3.52M
EPS -160.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Viveve Medical Enters Oversold Territory (VIVE)

Viveve Medical Enters Oversold Territory (VIVE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Ways Allergan Can Keep Up Momentum

5 Ways Allergan Can Keep Up Momentum

Allergan's most-recent quarterly financial report for Q4/2016 showed solid results.

Rebound May Be in Store for Beaten-Down Shares of TherapeuticsMD

Rebound May Be in Store for Beaten-Down Shares of TherapeuticsMD

Although many biotechnology stocks have fallen this year due to disappointing clinical trial results, what is the deal with this stock that is down precipitously despite encouraging R&D news?

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGU, EGP, GEL, ISLE, JVA, VG Downgrades: BOBE, CHKE, HDS, HOG, KFFB, MPAA, SCCO, WCC Initiations: VIVE Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: D- (Sell)